Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Blood concentrations of Ciprofol were measured at different time points after single injection in patients with hypoproteinemia
This study was a single-center, interventional clinical study. Patients with different plasma albumin levels were selected before surgery and induced by a single injection of Ciprofol at a depth of 0.3 mg/kg. 2ml of venous blood was collected before and 0.5, 1, 2, 3, 5, 8, 15, 30min, 1h, 2h and 4h after administration. The pharmacokinetics of Ciprofol were studied by measuring the concentration of Ciprofol in blood.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Severe Hypoproteinemia | Other | Blood albumin concentration≤30g/L |
|
| Moderate Hypoproteinemia | Other | Blood albumin concentration 30g/L-40g/L |
|
| Normal plasma albumin | Other | Blood albumin concentration >40g/L |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ciprofol | Drug | Patients who intended to undergo elective surgery under general anesthesia were induced by a single intravenous injection of 0.3mg/kg and ciprofol, and the experimental drug was manually injected by CVC within 30s. 2ml of venous blood was collected before and after administration 0.5min, 1min, 2min, 3min, 5min, 8min, 15min 30min, 1h, 2h and 4h respectively. The concentration of cyclopofol in blood was measured |
| Measure | Description | Time Frame |
|---|---|---|
| Blood concentrations at different time points after a single injection | Blood concentration of ciprofol | Before administration, after administration 0.5 minute, 1 minute, 2 minutes, 3 minutes, 5 minutes, 8 minutes, 15 minutes, 30 minutes, 1 hour, 2 hours, 4 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Onset time of ciprofol in patients with hypoproteinemia | The time it takes for the blood concentration of a drug to reach the clinically active concentration level from zero | Day 1 |
| Effect time of ciprofol in patients with hypoproteinemia |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| XIE Kangjie, doctoral | Zhejiang Cancer Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | Zhejang | 310000 | China |
Not provided
| ID | Term |
|---|---|
| D007019 | Hypoproteinemia |
| ID | Term |
|---|---|
| D001796 | Blood Protein Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C000730795 | (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
From the time the drug was administered to the time the patient lost consciousness
| Day 1 |